374 related articles for article (PubMed ID: 17023625)
1. Biodefense. House passes plan for drug, vaccine R&D.
Kaiser J
Science; 2006 Oct; 314(5796):39. PubMed ID: 17023625
[No Abstract] [Full Text] [Related]
2. Throwing money at biodefense.
DeFrancesco L
Nat Biotechnol; 2004 Apr; 22(4):375-8. PubMed ID: 15060542
[No Abstract] [Full Text] [Related]
3. Bioterrorism. Congress adopts tough rules for labs.
Malakoff D
Science; 2002 May; 296(5573):1585-7. PubMed ID: 12040151
[No Abstract] [Full Text] [Related]
4. Biodefense. Critics question proposed countermeasures agency.
Kaiser J
Science; 2005 Nov; 310(5749):755. PubMed ID: 16272086
[No Abstract] [Full Text] [Related]
5. ELSI and bioterrorism countermeasures?
Green SK
Nat Biotechnol; 2004 Jun; 22(6):656. PubMed ID: 15175678
[No Abstract] [Full Text] [Related]
6. Public Health and biosecurity. The limits of government regulation of science.
Kraemer JD; Gostin LO
Science; 2012 Mar; 335(6072):1047-9. PubMed ID: 22267583
[No Abstract] [Full Text] [Related]
7. Biosecurity. New biosecurity rules to target the riskiest pathogens.
Bhattacharjee Y
Science; 2010 Jul; 329(5989):264-5. PubMed ID: 20647433
[No Abstract] [Full Text] [Related]
8. Managing science. House votes to kill grants, limit travel to meetings.
Kaiser J
Science; 2004 Sep; 305(5691):1688. PubMed ID: 15375232
[No Abstract] [Full Text] [Related]
9. Homeland security plan sparks fears for fight against bioterror.
Brumfiel G
Nature; 2002 Jun; 417(6890):675. PubMed ID: 12066141
[No Abstract] [Full Text] [Related]
10. Homeland security. New agency contains strong science arm.
Malakoff D
Science; 2002 Nov; 298(5598):1534. PubMed ID: 12446877
[No Abstract] [Full Text] [Related]
11. Cost/success projections for US biodefense countermeasure development.
Matheny J; Mair M; Smith B
Nat Biotechnol; 2008 Sep; 26(9):981-3. PubMed ID: 18779804
[No Abstract] [Full Text] [Related]
12. Biodefense funding: changes from president's budget to congressional appropriations.
Sell TK; Gilles K; Franco C
Biosecur Bioterror; 2012 Sep; 10(3):321-7. PubMed ID: 22897593
[No Abstract] [Full Text] [Related]
13. Prospect of stricter timekeeping alarms US biologists.
Marris E
Nature; 2005 Dec; 438(7069):721. PubMed ID: 16340976
[No Abstract] [Full Text] [Related]
14. Bioterrorism. BioShield is slow to build U.S. defenses against bioweapons.
Kaiser J
Science; 2006 Jul; 313(5783):28-9. PubMed ID: 16825542
[No Abstract] [Full Text] [Related]
15. Billions for biodefense: federal agency biodefense funding, FY2001-FY2005.
Schuler A
Biosecur Bioterror; 2004; 2(2):86-96. PubMed ID: 15225402
[TBL] [Abstract][Full Text] [Related]
16. Bioterrorism. Congress weighs select agent update.
Enserink M; Malakoff D
Science; 2001 Nov; 294(5546):1438. PubMed ID: 11711649
[No Abstract] [Full Text] [Related]
17. Biodefense. U.S. agencies unveil plan for biosecurity peer review.
Couzin J
Science; 2004 Mar; 303(5664):1595. PubMed ID: 15016970
[No Abstract] [Full Text] [Related]
18. Biological agents. New U.S. rules set the stage for tighter security, oversight.
Malakoff D
Science; 2002 Dec; 298(5602):2304. PubMed ID: 12493881
[No Abstract] [Full Text] [Related]
19. Kentucky nurse testifies in Washington, D.C. Testimony on nursing education and research funding before the Labor, Health and Human Services, Education and Related Agencies Subcommittee of the House Appropriations Committee, April 28, 1992.
Browning D
Ky Nurse; 1992; 40(3):21, 23. PubMed ID: 1625465
[No Abstract] [Full Text] [Related]
20. Priority review vouchers: an inefficient and dangerous way to promote neglected-disease drug development.
Kesselheim AS
Clin Pharmacol Ther; 2009 Jun; 85(6):573-5. PubMed ID: 19451908
[No Abstract] [Full Text] [Related]
[Next] [New Search]
